NOTICE OF UPGRADE
Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022
SEARCH LISTED COMPANY
Any AUS or NZ company
SEARCH PRIVATE COMPANY
SEARCH FUNDS
Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
05 October 2024
| Name: | BONE MEDICAL LIMITED (BNE) (This company subsequently changed its name to BOTANIX PHARMACEUTICALS LTD. You should refer to that name for Status.) | ||||||||||||
| Date of Listing: | 24 January 1985 | ||||||||||||
| Subsequent Names: |
| ||||||||||||
| Former Names: |
|
Stock Exchange Status: (updated daily)
This company subsequently changed its name to BOTANIX PHARMACEUTICALS LTD. You should refer to that name for Stock Exchange Status.Legal Status: (updated monthly)
This company subsequently changed its name to BOTANIX PHARMACEUTICALS LTD. You should refer to that name for Legal Status.Capital Gains Tax (CGT) Status: (updated at least quarterly)
This company subsequently changed its name and is now BOTANIX PHARMACEUTICALS LTD. You should refer to that name for Capital Gains Tax Status.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| FROM | TO | |
| BOTANIX PHARMACEUTICALS LTD | 07/07/2016 | |
| BONE MEDICAL LIMITED | 20/08/2004 | 07/07/2016 |
| REVENIR LIMITED | 22/01/2004 | 20/08/2004 |
| ALIQUOT ASSET MANAGEMENT LIMITED | 20/08/2001 | 22/01/2004 |
| AERODATA HOLDINGS LIMITED | 20/08/2001 |
Automic Registry Pty Ltd
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail
Expand this box to read and print
name changed to Botanix Pharmaceuticals Ltd | 07/07/2016 |
The company is pleased to announce the completion of the transaction to acquire the entire issued capital of Botanix Pharmaceuticals, Inc. by way of a merger to become Botanix Pharmaceuticals Limited. The agreements between the Company and the shareholders of Botanix have been completed. In addition, the Company has raised $3.5 million under the public offer pursuant to the Prospectus and Supplementary Prospectus. | 04/07/2016 |
we understand that on or about this date the company consolidated its shares 1000 for 3333 | 28/06/2016 |
we understand that on or about this date the company consolidated its shares 1000 for 3333 | 28/06/2016 |
The company is pleased to announce that the Prospectus Offer for the acquisition of Botanix Pharmaceuticals has closed heavily oversubscribed following strong support from investors. | 27/06/2016 |
The company issues a supplementary prospectus intended to be read with the prospectus dated 13 May 2016, issued by Bone Medical Limited. | 24/06/2016 |
The company announces the results of its meeting. | 14/06/2016 |
The securities of Bone Medical Limited ("Company") will be suspended from official quotation immediately, pending the outcome of a resolution at the Company's general meeting to approve a change in the nature and scale of the Company's activities. The Company's securities will remain suspended pending compliance with Chapters 1 and 2 of the Listing Rules. | 14/06/2016 |
we understand that on or about this date the company consolidated its shares 1 for 50 | 24/01/2014 |
The suspension of trading in the securities of Bone Medical Limited (the "Company") will be lifted prior to the commencement of trading tomorrow, Thursday 29 August 2013, pursuant to Listing Rule 17.9, following the payment of annual listing fees for the year ending 30 June 2014 by the Company. Security Code: BNE | 28/08/2013 |
Under listing rule 17.6, any entity (if not already suspended) that had not paid its annual listing fees by close of business on Thursday 22 August 2013 is to be suspended from official quotation before the commencement of trading on Friday 23 August 2013. The company has failed to pay to ASX Limited their annual listing fees in respect of the year ending 30 June 2014 and consequently will be suspended from quotation immediately. | 23/08/2013 |
securities reinstated to quotation | 08/03/2011 |
suspended from quotation following failure to lodge its half yearly financial report | 01/03/2011 |
securities reinstated to quotation | 19/12/2007 |
securities suspended from quotation pending an announcement | 13/12/2007 |
we understand that on or about this date the company consolidated its shares 1 for 4 | 23/08/2004 |
name changed from Revenir Limited | 20/08/2004 |
name changed to Botanix Pharmaceuticals Ltd | 07/07/2016 |
The company is pleased to announce the completion of the transaction to acquire the entire issued capital of Botanix Pharmaceuticals, Inc. by way of a merger to become Botanix Pharmaceuticals Limited. The agreements between the Company and the shareholders of Botanix have been completed. In addition, the Company has raised $3.5 million under the public offer pursuant to the Prospectus and Supplementary Prospectus. | 04/07/2016 |
we understand that on or about this date the company consolidated its shares 1000 for 3333 | 28/06/2016 |
we understand that on or about this date the company consolidated its shares 1000 for 3333 | 28/06/2016 |
The company is pleased to announce that the Prospectus Offer for the acquisition of Botanix Pharmaceuticals has closed heavily oversubscribed following strong support from investors. | 27/06/2016 |
The company issues a supplementary prospectus intended to be read with the prospectus dated 13 May 2016, issued by Bone Medical Limited. | 24/06/2016 |
The company announces the results of its meeting. | 14/06/2016 |
The securities of Bone Medical Limited ("Company") will be suspended from official quotation immediately, pending the outcome of a resolution at the Company's general meeting to approve a change in the nature and scale of the Company's activities. The Company's securities will remain suspended pending compliance with Chapters 1 and 2 of the Listing Rules. | 14/06/2016 |
we understand that on or about this date the company consolidated its shares 1 for 50 | 24/01/2014 |
The suspension of trading in the securities of Bone Medical Limited (the "Company") will be lifted prior to the commencement of trading tomorrow, Thursday 29 August 2013, pursuant to Listing Rule 17.9, following the payment of annual listing fees for the year ending 30 June 2014 by the Company. Security Code: BNE | 28/08/2013 |
Under listing rule 17.6, any entity (if not already suspended) that had not paid its annual listing fees by close of business on Thursday 22 August 2013 is to be suspended from official quotation before the commencement of trading on Friday 23 August 2013. The company has failed to pay to ASX Limited their annual listing fees in respect of the year ending 30 June 2014 and consequently will be suspended from quotation immediately. | 23/08/2013 |
securities reinstated to quotation | 08/03/2011 |
suspended from quotation following failure to lodge its half yearly financial report | 01/03/2011 |
securities reinstated to quotation | 19/12/2007 |
securities suspended from quotation pending an announcement | 13/12/2007 |
we understand that on or about this date the company consolidated its shares 1 for 4 | 23/08/2004 |
name changed from Revenir Limited | 20/08/2004 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|
| 10/04/2015 | Robert Towner | -2,500,000 | $0.013 | $32,440 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Robert Towner | Non Exec Chairman | 28/01/2014 |
| Graham Griffiths | Non Exec Chairman | 01/07/2016 |
| Peter Young | Managing Director, CEO | 05/04/2011 |
| William Bosch | Executive Director | 01/07/2016 |
| Matt Callahan | Executive Director | 01/07/2016 |
| Brett Tucker | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Phillip Wingate | Non Exec Director | 27/11/2014 | 01/07/2016 |
| John Hannaford | Non Exec Director | 28/01/2014 | 01/07/2016 |
| Roger New | Non Exec Director | 02/06/2005 | 27/11/2014 |
| Leon Ivory | Director | 16/11/2005 | 24/01/2014 |
| Peter Brooks | Director | 25/07/2007 | 24/01/2014 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2024 Investogain Pty Limited. All rights reserved.
